Bioreactor for submerged cultivation of fungi and microorganisms in a controlled sterile cycle. This equipment moves CryoVit from the category of “ingredient producer” to the category of a technology platform where cultivation, metabolic management and subsequent extraction work as a single system.
The equipment brings together medium preparation, sterilization, cultivation, remote control and a data-ready layer for further extraction and standardization of active substances.
The bioreactor removes the dependence on the season, substrate and random fluctuations of the environment. Instead, CryoVit receives a controlled liquid system where nutrients, oxygen, pH, and temperature work for a steady output of biomass and metabolites.
SmF allows you to work not only with the growth of mycelium, but also with the controlled synthesis of erinacins, cordycepin and extracellular polysaccharides. This is especially important for CryoVit because the active substance becomes not a random outcome but a programmed goal.
A closed sterile loop reduces the risk of contamination, and automation makes the process faster and cheaper for B2B scaling. This is a strong argument for brands that value both quality and market entry.
Historically, cordyceps and other medicinal mushrooms have been associated with wild gathering, seasonality, and rarity. Even traditional farming methods remained slow and dependent on the substrate. The bioreactor changes the very logic: instead of a random natural cycle, a controlled biotechnological platform appears that can reproduce valuable fractions faster, cleaner and more stably.
| Parameter | Traditional farms / wild harvesting | CryoVit bioreactor |
|---|---|---|
| Purity | Medium to high risk of outside contamination, heavy metals, and stray microorganisms. | Sterile closed-loop process with more predictable quality and lower contamination risk. |
| Cycle speed | Slower growth with strong dependence on season and substrate. | Cycle reduction to roughly 7–14 days with better batch repeatability. |
| Active compounds | Unstable profile with strong dependence on external conditions. | Controlled conditions make it easier to target mycelium, erinacins, cordycepin, and EPS fractions. |
| Scale-up | Requires large areas and more complex agricultural handling. | A compact biotechnology model that is easier to scale for B2B production. |
This page shows how the bioreactor becomes the backbone of the entire CryoVit platform: from mycelium cultivation and metabolite control to downstream extraction, purification, microdrop technology and lyophilization.
